rs3218713
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000257.4(MYH7):c.746G>T(p.Arg249Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R249Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.746G>T | p.Arg249Leu | missense_variant | 9/40 | ENST00000355349.4 | NP_000248.2 | |
MYH7 | NM_001407004.1 | c.746G>T | p.Arg249Leu | missense_variant | 8/39 | NP_001393933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.746G>T | p.Arg249Leu | missense_variant | 9/40 | 1 | NM_000257.4 | ENSP00000347507 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Mar 23, 2017 | - - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2019 | The p.R249L variant (also known as c.746G>T), located in coding exon 7 of the MYH7 gene, results from a G to T substitution at nucleotide position 746. The arginine at codon 249 is replaced by leucine, an amino acid with dissimilar properties. Other alterations affecting the same amino acid, p.R249Q (c.746G>A) and p.R249G (c.745C>G), have been reported in association with hypertrophic cardiomyopathy (HCM) and left ventricular non-compaction (LVNC) (Rosenzweig A et al. N. Engl. J. Med. 1991;325:1753-60; Tian T et al. Heart Vessels. 2015;30:258-64). In addition, this variant has been determined to be the result of a de novo mutation or germline mosaicism in one family with an isolated case of restrictive cardiomyopathy (Ambry internal data).This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Hypertrophic cardiomyopathy 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at